123 related articles for article (PubMed ID: 1369022)
1. Controlled antibody delivery systems.
Sherwood JK; Dause RB; Saltzman WM
Biotechnology (N Y); 1992 Nov; 10(11):1446-9. PubMed ID: 1369022
[TBL] [Abstract][Full Text] [Related]
2. Controlled DNA delivery systems.
Luo D; Woodrow-Mumford K; Belcheva N; Saltzman WM
Pharm Res; 1999 Aug; 16(8):1300-8. PubMed ID: 10468035
[TBL] [Abstract][Full Text] [Related]
3. Biodegradable micelles/polymersomes from fumaric/sebacic acids and poly(ethylene glycol).
Najafi F; Sarbolouki MN
Biomaterials; 2003 Mar; 24(7):1175-82. PubMed ID: 12527258
[TBL] [Abstract][Full Text] [Related]
4. Controlled release of macromolecules from a degradable polyanhydride matrix.
Dang W; Saltzman WM
J Biomater Sci Polym Ed; 1994; 6(3):297-311. PubMed ID: 7527250
[TBL] [Abstract][Full Text] [Related]
5. New polymeric carriers for controlled drug delivery following inhalation or injection.
Fu J; Fiegel J; Krauland E; Hanes J
Biomaterials; 2002 Nov; 23(22):4425-33. PubMed ID: 12219833
[TBL] [Abstract][Full Text] [Related]
6. Stabilization of nerve growth factor in controlled release polymers and in tissue.
Krewson CE; Dause R; Mak M; Saltzman WM
J Biomater Sci Polym Ed; 1996; 8(2):103-17. PubMed ID: 8957707
[TBL] [Abstract][Full Text] [Related]
7. Intracranial delivery of recombinant nerve growth factor: release kinetics and protein distribution for three delivery systems.
Saltzman WM; Mak MW; Mahoney MJ; Duenas ET; Cleland JL
Pharm Res; 1999 Feb; 16(2):232-40. PubMed ID: 10100308
[TBL] [Abstract][Full Text] [Related]
8. Controlled vaginal delivery of antibodies in the mouse.
Radomsky ML; Whaley KJ; Cone RA; Saltzman WM
Biol Reprod; 1992 Jul; 47(1):133-40. PubMed ID: 1637941
[TBL] [Abstract][Full Text] [Related]
9. Poly(sebacic acid-co-ricinoleic acid) biodegradable carrier for paclitaxel: in vitro release and in vivo toxicity.
Shikanov A; Vaisman B; Krasko MY; Nyska A; Domb AJ
J Biomed Mater Res A; 2004 Apr; 69(1):47-54. PubMed ID: 14999750
[TBL] [Abstract][Full Text] [Related]
10. Stable polyanhydride synthesized from sebacic acid and ricinoleic acid.
Haim-Zada M; Basu A; Hagigit T; Schlinger R; Grishko M; Kraminsky A; Hanuka E; Domb AJ
J Control Release; 2017 Jul; 257():156-162. PubMed ID: 27126904
[TBL] [Abstract][Full Text] [Related]
11. Hydrolytic degradation of ricinoleic-sebacic-ester-anhydride copolymers.
Krasko MY; Domb AJ
Biomacromolecules; 2005; 6(4):1877-84. PubMed ID: 16004424
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of polyanhydride for local BCNU delivery carriers.
Kim MS; Seo KS; Seong HS; Cho SH; Lee HB; Hong KD; Kim SK; Khang G
Biomed Mater Eng; 2005; 15(3):229-38. PubMed ID: 15912003
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization and in vitro degradation of a new family of alternate poly(ester-anhydrides) based on aliphatic and aromatic diacids.
Jiang HL; Zhu KJ
Biomaterials; 2001 Feb; 22(3):211-8. PubMed ID: 11197496
[TBL] [Abstract][Full Text] [Related]
14. Poly(fumaric-co-sebacic anhydride). A degradation study as evaluated by FTIR, DSC, GPC and X-ray diffraction.
Santos CA; Freedman BD; Leach KJ; Press DL; Scarpulla M; Mathiowitz E
J Control Release; 1999 Jun; 60(1):11-22. PubMed ID: 10370167
[TBL] [Abstract][Full Text] [Related]
15. In vitro release of model compounds with different hydrophilicity from poly(ester-anhydride) microspheres.
Jaszcz K
Acta Pol Pharm; 2013; 70(6):1051-63. PubMed ID: 24383329
[TBL] [Abstract][Full Text] [Related]
16. Synthetic, implantable, biodegradable polymers for controlled release of radiosensitizers.
Yuan X; Fahlman C; Tabassi K; Williams JA
Cancer Biother Radiopharm; 1999 Jun; 14(3):177-86. PubMed ID: 10850302
[TBL] [Abstract][Full Text] [Related]
17. Alternating Poly(ester-anhydride) by Insertion Polycondensation.
Haim-Zada M; Basu A; Hagigit T; Schlinger R; Grishko M; Kraminsky A; Hanuka E; Domb AJ
Biomacromolecules; 2016 Jun; 17(6):2253-9. PubMed ID: 27198864
[TBL] [Abstract][Full Text] [Related]
18. Surface modification of polyanhydride microspheres.
Gao J; Niklason L; Zhao XM; Langer R
J Pharm Sci; 1998 Feb; 87(2):246-8. PubMed ID: 9519161
[No Abstract] [Full Text] [Related]
19. Poly(ether-anhydride) dry powder aerosols for sustained drug delivery in the lungs.
Fiegel J; Fu J; Hanes J
J Control Release; 2004 May; 96(3):411-23. PubMed ID: 15120898
[TBL] [Abstract][Full Text] [Related]
20. Polymers for the controlled release of macromolecules: effect of molecular weight of ethylene-vinyl acetate copolymer.
Hsu TT; Langer R
J Biomed Mater Res; 1985 Apr; 19(4):445-60. PubMed ID: 4055827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
